非小細胞肺癌治療薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04515 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、非小細胞肺癌治療薬の世界市場について調査・分析し、非小細胞肺癌治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（生物製剤、小分子）、用途別（病院、クリニック）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の非小細胞肺癌治療薬市場動向 ・主要企業別マーケットシェア ・非小細胞肺癌治療薬の種類別市場規模2014-2019 （生物製剤、小分子） ・非小細胞肺癌治療薬の用途別市場規模2014-2019 （病院、クリニック） ・非小細胞肺癌治療薬の北米市場：主要企業・種類別/用途別市場規模 ・非小細胞肺癌治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・非小細胞肺癌治療薬の中国市場：主要企業・種類別/用途別市場規模 ・非小細胞肺癌治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・非小細胞肺癌治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・非小細胞肺癌治療薬のインド市場：主要企業・種類別/用途別市場規模 ・非小細胞肺癌治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GlaxoSmithKline、Novartis、AstraZeneca、Roche、Bristol-Myers Squibb、Pfizer、Eli Lilly、Sanofi） ・非小細胞肺癌治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Lung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness of breath. Due an increase in the incidence of lung cancer, the global lung cancer therapeutics market is expected to expand at a rapid pace.Non-small cell lung cancer is the most common type of lung cancer that causes mortality and morbidity in both developed and developing countries. The approval of late-stage pipeline products like onartuzumab and necitumumab is expected to foster growth in this market, resulting in its steady market growth.
In 2018, the global Non-Small Cell Lung Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Non-Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Small Cell Lung Cancer Therapeutics development in United States, Europe and China.

The key players covered in this study
GlaxoSmithKline
Novartis
AstraZeneca
Roche
Bristol-Myers Squibb
Pfizer
Eli Lilly
Sanofi

Market segment by Type, the product can be split into
Biologics
Small molecules

Market segment by Application, split into
Hospital
Clinic

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Non-Small Cell Lung Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-Small Cell Lung Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Biologics
1.4.3 Small molecules
1.5 Market by Application
1.5.1 Global Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Non-Small Cell Lung Cancer Therapeutics Market Size
2.2 Non-Small Cell Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Non-Small Cell Lung Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Non-Small Cell Lung Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Non-Small Cell Lung Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Non-Small Cell Lung Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
5.2 Non-Small Cell Lung Cancer Therapeutics Key Players in United States
5.3 United States Non-Small Cell Lung Cancer Therapeutics Market Size by Type
5.4 United States Non-Small Cell Lung Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
6.2 Non-Small Cell Lung Cancer Therapeutics Key Players in Europe
6.3 Europe Non-Small Cell Lung Cancer Therapeutics Market Size by Type
6.4 Europe Non-Small Cell Lung Cancer Therapeutics Market Size by Application

7 China
7.1 China Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
7.2 Non-Small Cell Lung Cancer Therapeutics Key Players in China
7.3 China Non-Small Cell Lung Cancer Therapeutics Market Size by Type
7.4 China Non-Small Cell Lung Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
8.2 Non-Small Cell Lung Cancer Therapeutics Key Players in Japan
8.3 Japan Non-Small Cell Lung Cancer Therapeutics Market Size by Type
8.4 Japan Non-Small Cell Lung Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
9.2 Non-Small Cell Lung Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size by Application

10 India
10.1 India Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
10.2 Non-Small Cell Lung Cancer Therapeutics Key Players in India
10.3 India Non-Small Cell Lung Cancer Therapeutics Market Size by Type
10.4 India Non-Small Cell Lung Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
11.2 Non-Small Cell Lung Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size by Type
11.4 Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-Small Cell Lung Cancer Therapeutics Introduction
12.1.4 GlaxoSmithKline Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-Small Cell Lung Cancer Therapeutics Introduction
12.2.4 Novartis Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-Small Cell Lung Cancer Therapeutics Introduction
12.3.4 AstraZeneca Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-Small Cell Lung Cancer Therapeutics Introduction
12.4.4 Roche Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-Small Cell Lung Cancer Therapeutics Introduction
12.5.4 Bristol-Myers Squibb Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-Small Cell Lung Cancer Therapeutics Introduction
12.6.4 Pfizer Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-Small Cell Lung Cancer Therapeutics Introduction
12.7.4 Eli Lilly Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.7.5 Eli Lilly Recent Development
12.8 Sanofi
12.8.1 Sanofi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-Small Cell Lung Cancer Therapeutics Introduction
12.8.4 Sanofi Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.8.5 Sanofi Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Non-Small Cell Lung Cancer Therapeutics Key Market Segments
Table Key Players Non-Small Cell Lung Cancer Therapeutics Covered
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure Biologics Figures
Table Key Players of Biologics
Figure Small molecules Figures
Table Key Players of Small molecules
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Non-Small Cell Lung Cancer Therapeutics Report Years Considered
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Non-Small Cell Lung Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Non-Small Cell Lung Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-Small Cell Lung Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Non-Small Cell Lung Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Non-Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Non-Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Non-Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table United States Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Non-Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table Europe Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Non-Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Non-Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Non-Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table China Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table China Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Non-Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table Japan Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Non-Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Non-Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Non-Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table India Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table India Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Roche Company Details
Table Roche Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Non-Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Non-Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Non-Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Non-Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size by Product in 2025
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---